English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background   Little is known about the underlying causes of differences in immunological response to antiretroviral therapy during multidrug-resistant (MDR) HIV type-1 (HIV-1) infection. This study aimed to identify virological factors associated with immunological response during therapy failure.Methods   Individuals with MDR HIV-1 receiving therapy for ≥3 months were included. CD4 +  T-cell count slopes and pol and clonal env sequences were determined. Genetic analyses were performed using distance-based and maximum likelihood methods. Synonymous mutations rates of env were used to estimate viral replication.Results   Of 1,000 patients treated between 1995 and 2003, 72 individuals fulfilled the definition for triple-class failure, but 25 were non-compliant, 21 were successfully resuppressed and 3 had died or quit therapy. Of the 23 that fulfilled study criteria, 16 had samples available for analysis. In a longitudinal mixed-effects model, plasma HIV-1 RNA only tended to predict immunological response ( P=0.06), whereas minor protease inhibitor (PI) and nucleoside reverse transcriptase (NRTI) mutations at baseline correlated significantly with CD4 +  T-cell count slopes ( r=-0.56, P=0.04 and r=-0.64, P=0.008, respectively). Interestingly, synonymous mutations of env correlated inversely with CD4 +  T-cell count slopes ( r=-0.60; P=0.01) and individuals with codons under positive selection had significantly better CD4 +  T-cell responses than individuals without (0.42 versus -5.34; P=0.02).Conclusions   Our results suggest that minor PI mutations and NRTI mutations present early during therapy failure are predictive of the CD4 +  T-cell count slopes. Synonymous mutation rates of the env gene suggested that underlying differences in fitness could cause this association.

antiviral therapy

Immunological responses during a virologically failing antiretroviral regimen are associated with<i>in vivo</i>synonymous mutation rates of HIV type-1<i>env</i>

Immunological responses during a virologically failing antiretroviral regimen are associated within vivosynonymous mutation rates of HIV type-1env